PORTLAND, Ore. (AP) — Oregon Attorney General Ellen Rosenblum says the state will get nearly $4 million in a multistate settlement with a British drug maker over the diabetes drug Avandia.
Rosenblum said in a statement Thursday that GlaxoSmithKline will pay $90 million to 38 states to settle a suit alleging it misrepresented the cardiovascular risks of the drug.
The attorney general said that a 2007 study linked Avandia to increased risk of heart attacks, a condition diabetics are predisposed to, and Avandia sales plummeted amid consumer lawsuits.
In 2010, the diabetes drug was restricted in the U.S. and banned in Europe.
Rosenblum's statement says the settlement requires the company to change its marketing practices. The company did not immediately return a call seeking comment.